These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7978823)
41. Influence of successive and combined ultraviolet A and B irradiations on matrix metalloelastases produced by human dermal fibroblasts in culture. Kut C; Hornebeck W; Groult N; Redziniack G; Godeau G; Pellat B Cell Biol Int; 1997 Jun; 21(6):347-52. PubMed ID: 9268487 [TBL] [Abstract][Full Text] [Related]
42. MMPs are IGFBP-degrading proteinases: implications for cell proliferation and tissue growth. Fowlkes JL; Serra DM; Nagase H; Thrailkill KM Ann N Y Acad Sci; 1999 Jun; 878():696-9. PubMed ID: 10415811 [No Abstract] [Full Text] [Related]
43. Increased MMP-9 activity in acute carotid plaques: therapeutic avenues to prevent stroke. Loftus IM; Goodall S; Crowther M; Jones L; Bell PR; Naylor AR; Thompson MM Ann N Y Acad Sci; 1999 Jun; 878():551-4. PubMed ID: 10415770 [No Abstract] [Full Text] [Related]
44. In situ activity of gelatinases during Lewis lung carcinoma progression. Tucker GC; Ferry G; Provent S; Atassi G Ann N Y Acad Sci; 1999 Jun; 878():534-7. PubMed ID: 10415765 [No Abstract] [Full Text] [Related]
45. The regulation of MMPs and TIMPs in cartilage turnover. Cawston T; Billington C; Cleaver C; Elliott S; Hui W; Koshy P; Shingleton B; Rowan A Ann N Y Acad Sci; 1999 Jun; 878():120-9. PubMed ID: 10415724 [TBL] [Abstract][Full Text] [Related]
46. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase by myofibroblasts--morphological study on corneal wound healing]. Shimoda M; Ishizaki M; Saiga T; Yamanaka N Nippon Ganka Gakkai Zasshi; 1997 May; 101(5):371-9. PubMed ID: 9170840 [TBL] [Abstract][Full Text] [Related]
47. The influence of bone and marrow on cartilage hypertrophy and degradation during 30-day serum-free culture of the embryonic chick tibia. Cole AA; Luchene LJ; Linsenmayer TF; Schmid TM Dev Dyn; 1992 Mar; 193(3):277-85. PubMed ID: 1600246 [TBL] [Abstract][Full Text] [Related]
48. Matrix metalloproteinase expression in human retinal microvascular cells. Grant MB; Caballero S; Tarnuzzer RW; Bass KE; Ljubimov AV; Spoerri PE; Galardy RE Diabetes; 1998 Aug; 47(8):1311-7. PubMed ID: 9703333 [TBL] [Abstract][Full Text] [Related]
49. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? Mäkelä M; Salo T; Larjava H Biochem Biophys Res Commun; 1998 Dec; 253(2):325-35. PubMed ID: 9878537 [TBL] [Abstract][Full Text] [Related]
51. Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures. Kawashima-Ohya Y; Satakeda H; Kuruta Y; Kawamoto T; Yan W; Akagawa Y; Hayakawa T; Noshiro M; Okada Y; Nakamura S; Kato Y Endocrinology; 1998 Apr; 139(4):2120-7. PubMed ID: 9529001 [TBL] [Abstract][Full Text] [Related]
52. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells. Meade-Tollin LC; Way D; Witte MH Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293 [TBL] [Abstract][Full Text] [Related]
53. Matrix metalloproteinase-9 in tumor cell invasion. French DL; Ramos-DeSimone N; Rozinski K; Nuovo GJ Ann N Y Acad Sci; 1994 Sep; 732():324-34. PubMed ID: 7978802 [No Abstract] [Full Text] [Related]
54. Effect of gonadotrophin on cell and matrix retention and expression of metalloproteinases and their inhibitor in cultured human granulosa cells modelling corpus luteum function. Aston KE; Stamouli A; Thomas EJ; Vyas S; Iredale JP; Arthur MJ; Richardson MC Mol Hum Reprod; 1996 Jan; 2(1):26-30. PubMed ID: 9238653 [TBL] [Abstract][Full Text] [Related]
55. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis. Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524 [TBL] [Abstract][Full Text] [Related]
56. Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease. Peters CA; Freeman MR; Fernandez CA; Shepard J; Wiederschain DG; Moses MA Am J Physiol; 1997 Jun; 272(6 Pt 2):R1960-5. PubMed ID: 9227614 [TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinases and TIMP-1 localization at sites of osteogenesis in the craniofacial region of the rabbit embryo. Breckon JJ; Hembry RM; Reynolds JJ; Meikle MC Anat Rec; 1995 Jun; 242(2):177-87. PubMed ID: 7668402 [TBL] [Abstract][Full Text] [Related]
58. Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis. Seftor EA; Seftor RE; Nieva DR; Hendrix MJ Adv Dent Res; 1998 Nov; 12(2):103-10. PubMed ID: 9972131 [No Abstract] [Full Text] [Related]
59. [Matrix metalloproteinases and their biological functions]. Solov'eva NI Bioorg Khim; 1998 Apr; 24(4):245-55. PubMed ID: 9612566 [TBL] [Abstract][Full Text] [Related]
60. Production of gelatinases and tissue inhibitors of matrix metalloproteinases by equine ovarian stromal cells In vitro. Song L; Porter DG; Coomber BL Biol Reprod; 1999 Jan; 60(1):1-7. PubMed ID: 9858479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]